Latest Transformation News

Enlitic has announced a strategic collaboration with GE HealthCare to deploy AI-driven technology that will transform the migration of medical imaging data, promising faster, more secure transitions and enhanced data quality for healthcare providers worldwide.

Opthea has completed the final patient visit in its pivotal COAST Phase 3 trial evaluating sozinibercept combined with aflibercept for wet AMD, with topline results expected early Q2 2025.

Brightstar Resources Limited reveals an ambitious growth strategy targeting a significant production ramp-up in 2025, anchored by its Laverton and Menzies hubs and supported by a robust mineral resource base.

HMC Capital has reported a record half-year financial performance for 1H FY25, driven by explosive growth in private equity and digital infrastructure platforms, alongside ambitious fundraising initiatives in energy transition.

HMC Capital Limited has reported a remarkable 680% increase in profit for the half-year ended 31 December 2024, driven by key acquisitions and expansion into digital infrastructure and private credit sectors. The company also announced a fully franked interim dividend, underscoring confidence in its growth trajectory.

HUB24 has delivered a standout first half of FY25, posting record platform net inflows of $9.5 billion and a 40% rise in underlying net profit, reinforcing its position as a market leader in Australia’s wealth management sector.

SRG Global has reported a record first half for FY25, posting a 21% revenue increase and upgrading its full-year profit guidance, driven by strong cash flow and successful integration of the Diona acquisition.

SRG Global has delivered a record first half in FY25, posting strong revenue and profit growth alongside a successful acquisition integration that boosts its water security and energy transition capabilities.

Infratil has increased its investment in CDC Data Centres by acquiring an additional 1.58% stake for approximately A$216 million, reinforcing its commitment to the fast-growing digital infrastructure sector.

Simonds Group delivered a resilient $13.6 million EBITDA in 1H FY25 amid a soft residential market and announced a strategic acquisition of Dennis Family Homes to fuel future growth.

GWR is actively pursuing transformative project acquisitions across global jurisdictions while trading significantly below its cash and investment backing. The company’s robust cash position and critical minerals investments position it well amid shifting global supply dynamics.

PYC Therapeutics has launched a A$145.8 million pro-rata accelerated non-renounceable entitlement offer to fund late-stage clinical trials across its pipeline targeting rare diseases with high unmet needs. The capital raise aims to extend the company’s cash runway beyond FY27, supporting four drug candidates through critical human safety and efficacy milestones.